Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Optimal responses in disease activity scores to treatment in rheumatoid arthritis: Is a DAS28 reduction of >1.2 sufficient?

Fig. 2

Changes in EuroQol-5D (EQ5D) scores in four categories in moderate and good European League Against Rheumatism (EULAR) responders in both the cost-effectiveness of treatment strategies using combination of disease-modifying anti-rheumatic drugs and glucocorticoids in early rheumatoid arthritis (CARDERA), and tumour necrosis factor inhibitors against combination intensive therapy (TACIT) trials

Back to article page